P/E ratio for Xenetic Biosciences (XBIO)
P/E ratio as of May 2024 (TTM): -1.23
According to Xenetic Biosciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.22837. At the end of 2022 the company had a P/E ratio of -0.6064.
P/E ratio history for Xenetic Biosciences from 2016 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.6064 | -74.15% |
| 2021 | -2.35 | 94.3% |
| 2020 | -1.21 | 811.44% |
| 2019 | -0.1324 | -93.48% |
| 2018 | -2.03 | -55.55% |
| 2017 | -4.57 | 694.8% |
| 2016 | -0.5749 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.